Pain Relief for Birth Control Implants Insertion

Contraception Clinical Trial

Official title:

Topical Lidocaine-prilocaine Cream Versus Lidocaine Infiltration for Pain Relief During Insertion of Subcutaneous Birth Control Implants : A Randomized Controlled Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03187392
• Other study ID #: 123456
• Status: Active, not recruiting
• Phase: Phase 3
• First received: June 13, 2017
• Last updated: February 25, 2018
• Start date: June 12, 2017
• Est. completion date: September 18, 2018

Study information

• Verified date: February 2018
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of our study is to compare the analgesic effect of topical application of lidocaine-prilocaine cream and lidocaine infiltration during insertion of birth control implants

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 144
• Est. completion date: September 18, 2018
• Est. primary completion date: September 16, 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• female want use subcutaneous birth control

Exclusion Criteria:

• previous scar at side of insertion

Related Conditions & MeSH terms

• Contraception
• Lidocaine

Intervention

Drug:
• Lidocaine Injectable Product
3 cm of Lidocaine- will be injected subcutaneous for 5 minutes before insertion of subcutaneous birth control implant
• Lidocaine Topical Cream [LMX]
3 mg of Lidocaine- will be applied to skin for 5 minutes before insertion of subcutaneous birth control implant

Locations

Country	Name	City	State
Egypt	Medicine	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mean pain score during insertion of implant		10 minutes